MedPath

SAFLUTAN

SAFLUTAN

Discontinued
DIN Number

02425149

Drug Class

Human

Market Date

N/A

Company
HC

purdue pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02425149
AIG Number0155650001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EE05 TAFLUPROST
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:40.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

TAFLUPROSTActive
Strength: 4.5 MCG / 0.3 ML
Monograph: TAFLUPROST

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.